Telamon Group is proud to partner again with McLaren Health Care in their search for a dynamic and transformational leader to serve as the next President and Chief Executive Officer-McLaren Greater Lansing.
McLaren Greater Lansing is a tertiary teaching facility with 240 acute care beds, located in Lansing, Michigan on the southern edge of the Michigan State University campus. Among its services are a Level III Trauma Center/Emergency Department, Orthopedic and Sports Medicine Institute, comprehensive cardiac programs, medical/surgical units, and state-of-the-art women and children’s health services including a modern birthing center. Also located at the healthcare campus is the Karmanos Cancer Institute at McLaren Greater Lansing and Outpatient Care Center.
Residency programs are affiliated with Michigan State University College of Osteopathic Medicine, Michigan State University College of Human Medicine, and the Statewide Campus System. Residencies include family medicine, internal medicine, orthopedic surgery, general surgery, anesthesiology, and obstetrics/gynecology. Fellowships are offered in cardiology, hematology/oncology, gastroenterology, and pulmonary critical care. McLaren Greater Lansing also participates in a city wide residency programs in emergency medicine, neurology, urology, psychiatry, and physical and rehabilitation medicine.
McLaren Health Care, headquartered in Grand Blanc, Michigan, is a $7.7 billion, fully integrated health care delivery system committed to quality, evidence-based patient care and cost efficiency. The McLaren system includes 12 hospitals in Michigan, ambulatory surgery centers, imaging centers, a 1,300-member employed physician and advanced practice providers, commercial and Medicaid HMOs covering over 732,838 lives in Michigan and Indiana. McLaren includes home health, infusion and hospice providers, pharmacy services, a clinical laboratory network and a wholly owned medical malpractice insurance company. McLaren operates Michigan’s largest network of cancer centers and providers, anchored by the Karmanos Cancer Institute, a National Cancer Institute-designated comprehensive cancer centers. McLaren has 20,000 full-, part-time and contracted employees and over 113,000 network providers throughout Michigan, Indiana and Ohio.
As part of its Graduate Medical Education (GME) program, McLaren maintains academic affiliations with medical schools at Wayne State University, Michigan State University and Central Medical University. McLaren’s seven (7) GME campuses offer 38 residencies and eight (8) fellowship programs that train over 650 future physicians annually. All GME programs at McLaren are overseen and managed centrally by the Department of Academic Affairs. Additionally, McLaren partners with several Michigan-based Universities for nursing and allied health professional training. McLaren and Grand Valley State University have received several grants to train candidates in Doctor of Nursing Practice Programs; including primary care, behavioral health and other fields. A key strategic goal of McLaren is to grow partnerships to augment their clinical workforce.
All your information will be kept confidential according to EEO guidelines.
Telamon Group is transforming the recruiting industry. Our objective is to be a trusted consultant for all of your professional recruiting and placement needs. We will surround you with meaningful attention and create long-term relationships with our clients, candidates, and associates. We add economic value and waste neither time nor money. We strive to be a sophisticated, reliable and trusted recruitment consultant.
Telamon Group culture and methodologies drive superior business results. No one else is approaching executive recruitment the way we are. No one else is thinking about it the way we are. No one else is executing it the way we are. We continue to redefine the executive recruiting experience through the use of market data, analytics, and consistent and candid communication.
- Industries successfully served include: Hospital and Healthcare, Medical Devices, Pharmaceuticals
